Stock Scorecard
Stock Summary for Lilly(Eli) & Company (LLY) - $753.41 as of 11/20/2024 8:23:27 PM EST
Total Score
7 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for LLY
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for LLY
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for LLY
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for LLY
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for LLY (65 out of 90)
Stock Price Rating (Max of 10) | 10 |
Historical Stock Price Rating (Max of 10) | 10 |
Stock Price Trend (Max of 10) | 10 |
Book Value (Max of 10) | 6 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 5 |
Dividend Yield Percentage (Max of 10) | 1 |
Operating Margin (Max of 10) | 6 |
Trading Volume (Max of 10) | 10 |
Price to Earnings (Max of 10) | 2 |
Latest News for for LLY
Financial Details for LLY
Company Overview |
|
---|---|
Ticker | LLY |
Company Name | Lilly(Eli) & Company |
Country | USA |
Description | Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. |
Sector Name | LIFE SCIENCES |
Industry Name | PHARMACEUTICAL PREPARATIONS |
Most Recent Quarter | 9/30/2024 |
Next Earnings Date | 2/4/2025 |
Stock Price History |
|
Last Day Price | 753.41 |
Price 4 Years Ago | 161.45 |
Last Day Price Updated | 11/20/2024 8:23:27 PM EST |
Last Day Volume | 5,116,185 |
Average Daily Volume | 4,029,972 |
52-Week High | 970.92 |
52-Week Low | 558.01 |
Last Price to 52 Week Low | 35.02% |
Valuation Measures |
|
Trailing PE | 80.67 |
Industry PE | 22.60 |
Sector PE | 40.32 |
5-Year Average PE | 60.89 |
Free Cash Flow Ratio | 203.08 |
Industry Free Cash Flow Ratio | 12.03 |
Sector Free Cash Flow Ratio | 27.97 |
Current Ratio Most Recent Quarter | 1.27 |
Total Cash Per Share | 3.71 |
Book Value Per Share Most Recent Quarter | 15.82 |
Price to Book Ratio | 49.75 |
Industry Price to Book Ratio | 5.31 |
Sector Price to Book Ratio | 20.88 |
Price to Sales Ratio Twelve Trailing Months | 17.34 |
Industry Price to Sales Ratio Twelve Trailing Months | 11.82 |
Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
Analyst Buy Ratings | 15 |
Analyst Strong Buy Ratings | 7 |
Share Statistics |
|
Total Shares Outstanding | 949,316,000 |
Market Capitalization | 715,224,167,560 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | 11/15/2024 |
Last Dividend Amount | 1.30 |
Current Dividend Amount | 1.30 |
Total Years Dividend Increasing | 9 |
Trailing Annual Dividend Rate | 5.20 |
Trailing Annual Dividend Yield | 0.69% |
Forward Annual Dividend Rate | 5.98 |
Forward Annual Dividend Yield | 0.79% |
5-Year Dividend Payments Count | 20 |
3-Year Average Dividend Yield | 1.03% |
5-Year Average Dividend Yield | 1.36% |
1-Year Dividend Growth Rate Percentage | 15.31% |
3-Year Dividend Growth Rate Percentage | 15.30% |
5-Year Dividend Growth Rate Percentage | 15.05% |
All-Time Dividend Growth Rate Percentage | 8.44% |
Dividend Payout Ratio | 56.22% |
Income Statement |
|
Quarterly Earnings Growth YOY | 68.20% |
Annual Earnings Growth | -16.08% |
Reported EPS 12 Trailing Months | 9.25 |
Reported EPS Past Year | 7.68 |
Reported EPS Prior Year | 6.32 |
Net Income Twelve Trailing Months | 8,369,900,000 |
Net Income Past Year | 5,240,400,000 |
Net Income Prior Year | 6,244,800,000 |
Quarterly Revenue Growth YOY | 20.40% |
5-Year Revenue Growth | 9.69% |
Operating Margin Twelve Trailing Months | 0.40 |
Balance Sheet |
|
Total Cash Most Recent Quarter | 3,518,400,000 |
Total Cash Past Year | 2,927,700,000 |
Total Cash Prior Year | 2,211,800,000 |
Net Cash Position Most Recent Quarter | -26,306,000,000 |
Net Cash Position Past Year | -16,108,200,000 |
Long Term Debt Past Year | 19,035,900,000 |
Long Term Debt Prior Year | 14,815,300,000 |
Total Debt Most Recent Quarter | 29,824,400,000 |
Equity to Debt Ratio Past Year | 0.36 |
Equity to Debt Ratio Most Recent Quarter | 0.32 |
Total Stockholder Equity Past Year | 10,771,900,000 |
Total Stockholder Equity Prior Year | 10,649,800,000 |
Total Stockholder Equity Most Recent Quarter | 14,240,000,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | 1,399,800,000 |
Free Cash Flow Per Share Twelve Trailing Months | 1.47 |
Free Cash Flow Past Year | 792,500,000 |
Free Cash Flow Prior Year | 5,731,400,000 |
Options |
|
Put/Call Ratio | 1.05 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -24.41 |
MACD Signal | -23.34 |
20-Day Bollinger Lower Band | 783.26 |
20-Day Bollinger Middle Band | 887.06 |
20-Day Bollinger Upper Band | 990.85 |
Beta | 0.43 |
RSI | 39.29 |
50-Day SMA | 792.25 |
150-Day SMA | 511.56 |
200-Day SMA | 438.21 |
System |
|
Modified | 11/19/2024 5:34:27 AM EST |